These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 30448195)

  • 1. The Cost-Effectiveness of Corticosteroids for the Treatment of Community-Acquired Pneumonia.
    Pliakos EE; Andreatos N; Tansarli GS; Ziakas PD; Mylonakis E
    Chest; 2019 Apr; 155(4):787-794. PubMed ID: 30448195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing door-to-antibiotic time in community-acquired pneumonia: Controlled before-and-after evaluation and cost-effectiveness analysis.
    Barlow G; Nathwani D; Williams F; Ogston S; Winter J; Jones M; Slane P; Myers E; Sullivan F; Stevens N; Duffey R; Lowden K; Davey P
    Thorax; 2007 Jan; 62(1):67-74. PubMed ID: 16928714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Cost-Effectiveness of Rapid Diagnostic Testing for the Diagnosis of Bloodstream Infections with or without Antimicrobial Stewardship.
    Pliakos EE; Andreatos N; Shehadeh F; Ziakas PD; Mylonakis E
    Clin Microbiol Rev; 2018 Jul; 31(3):. PubMed ID: 29848775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and cost-effectiveness of antibiotic treatments for community acquired pneumonia (CAP) and acute exacerbations of chronic bronchitis (AECB).
    Lavoie F; Blais L; Castilloux AM; Scalera A; LeLorier J
    Can J Clin Pharmacol; 2005; 12(2):e212-7. PubMed ID: 15998960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Cost-effectiveness of Cefazolin Compared With Antistaphylococcal Penicillins for the Treatment of Methicillin-Sensitive
    Pliakos EE; Ziakas PD; Mylonakis E
    Open Forum Infect Dis; 2021 Nov; 8(11):ofab476. PubMed ID: 34746331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic utilization and cost analysis in hospitalized patients with community-acquired pneumonia.
    Stein GE; Mantz SL
    Hosp Pharm; 1995 Feb; 30(2):132-4, 137. PubMed ID: 10140526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of the cost-effectiveness relationship in the empirical treatment in patients with infections of the lower respiratory tract acquired in the community].
    Bertrán MJ; Trilla A; Codina C; Carné X; Ribas J; Asenjo MA
    Enferm Infecc Microbiol Clin; 2000 Nov; 18(9):445-51. PubMed ID: 11149168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential for cost-savings in the care of hospitalized low-risk community-acquired pneumonia patients in China.
    Zhou QT; He B; Zhu H
    Value Health; 2009; 12(1):40-6. PubMed ID: 18637052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of sparfloxacin compared with other oral antimicrobials in outpatient treatment of community-acquired pneumonia.
    Najib MM; Stein GE; Goss TF
    Pharmacotherapy; 2000 Apr; 20(4):461-9. PubMed ID: 10772376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Corticosteroids in community acquired pneumonia: Where are we in 2018?].
    Soumagne T; Rabbat A
    Rev Mal Respir; 2018 Oct; 35(8):813-827. PubMed ID: 30217573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Cost-Effectiveness Analysis of Obtaining Blood Cultures in Children Hospitalized for Community-Acquired Pneumonia.
    Andrews AL; Simpson AN; Heine D; Teufel RJ
    J Pediatr; 2015 Dec; 167(6):1280-6. PubMed ID: 26456740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic Analysis of Infectious Disease Consultation for Staphylococcus aureus Bacteremia Among Hospitalized Patients.
    Pliakos EE; Ziakas PD; Mylonakis E
    JAMA Netw Open; 2022 Sep; 5(9):e2234186. PubMed ID: 36173628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia.
    Houck PM; Bratzler DW; Nsa W; Ma A; Bartlett JG
    Arch Intern Med; 2004 Mar; 164(6):637-44. PubMed ID: 15037492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe community-acquired pneumonia: current management and future therapeutic alternatives.
    Garnacho-Montero J; Barrero-García I; Gómez-Prieto MG; Martín-Loeches I
    Expert Rev Anti Infect Ther; 2018 Sep; 16(9):667-677. PubMed ID: 30118377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The IMPROVE-GAP Trial aiming to improve evidence-based management of community-acquired pneumonia: study protocol for a stepped-wedge randomised controlled trial.
    Skinner EH; Lloyd M; Janus E; Ong ML; Karahalios A; Haines TP; Kelly AM; Shackell M; Karunajeewa H
    Trials; 2018 Feb; 19(1):88. PubMed ID: 29402313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community-acquired pneumonia: economics of inpatient medical care vis-à-vis clinical severity.
    Cupurdija V; Lazic Z; Petrovic M; Mojsilovic S; Cekerevac I; Rancic N; Jakovljevic M
    J Bras Pneumol; 2015; 41(1):48-57. PubMed ID: 25750674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cost-effectiveness analysis of ambulatory treatment for adult patients with community-acquired pneumonia: according to Japanese Respiratory Society guidelines].
    Morimoto T; Koyama H; Shimbo T; Fukui T
    Nihon Kokyuki Gakkai Zasshi; 2002 Jan; 40(1):17-25. PubMed ID: 11925912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical and economic study of community-acquired pneumonia between single versus combination therapy.
    Hasali MA; Ibrahim MI; Sulaiman SA; Ahmad Z; Hasali JB
    Pharm World Sci; 2005 Jun; 27(3):249-53. PubMed ID: 16096896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Community-acquired pneumonia: influence of the duration of intravenous antibiotic therapy on hospital stay and the cost-benefit ratio].
    Fernández Alvarez R; Gullón Blanco JA; Rubinos Cuadrado G; Jiménez Sosa A; Hernández García C; Medina Gonzálvez A; González Martín I
    Arch Bronconeumol; 2001 Oct; 37(9):366-70. PubMed ID: 11674935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of exclusively oral antibiotic therapy in patients hospitalized with nonsevere community-acquired pneumonia: a retrospective study and meta-analysis.
    Marras TK; Nopmaneejumruslers C; Chan CK
    Am J Med; 2004 Mar; 116(6):385-93. PubMed ID: 15006587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.